(Q88012708)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29523495%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

title

Predicting outcome and improving treatment for Lassa fever (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29523495%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

1 reference

1

Thomas W Geisbert

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29523495%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

publication date

6 March 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29523495%20AND%20SRC:MED&resulttype=core&format=json

Lancet Infectious Diseases

19 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29523495%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29523495%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29523495%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

page(s)

594-595

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29523495%20AND%20SRC:MED&resulttype=core&format=json

A prospective study of the epidemiology and ecology of Lassa fever

19 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930116-6

7 January 2021

Lassa fever in post-conflict sierra leone

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930116-6

7 January 2021

Clinical and laboratory predictors of Lassa fever outcome in a dedicated treatment facility in Nigeria: a retrospective, observational cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930116-6

7 January 2021

Successful delivery of RRT in Ebola virus disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930116-6

7 January 2021

Lassa fever encephalopathy: Lassa virus in cerebrospinal fluid but not in serum

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930116-6

7 January 2021

Pathogenesis of Lassa fever in cynomolgus macaques

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930116-6

7 January 2021

Field Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930116-6

7 January 2021

Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930116-6

7 January 2021

Development of a new vaccine for the prevention of Lassa fever

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930116-6

7 January 2021

A DNA vaccine delivered by dermal electroporation fully protects cynomolgus macaques against Lassa fever

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930116-6

7 January 2021

New Vaccines against Epidemic Infectious Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930116-6

7 January 2021

10.1016/S1473-3099(18)30116-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29523495%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

1 reference